FDA removal of decongestants made with ineffective drug would disrupt drug supply chain, experts say
In the event of administrative removal of these products, clinicians and consumers could substitute oral pseudoephedrine or intranasal decongestants such as phenylephrine or oxymetazoline, the authors say.